Back

What the 2016 guidelines say.

22 May 2016 (16:55 - 17:08)
Organised by:
Congress Presentation Part of: What a busy clinician needs to know about LCZ696 for heart failure Miscellaneous HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Piotr Ponikowski

Wroclaw Medical University, Wroclaw (Poland)

6 More presentations in this session

Presentation thumbnail
The drug and the PARADIGM-HF trial.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
What was it approved for in Europe – The EMA recommendations.
Doctor K. Prasad (London, GB)
Slides Video
Presentation thumbnail
LCZ696 and the use of biomarkers.
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
LCZ696 and Alzheimers?
Professor A. Zeiher (Frankfurt, DE)
Slides Video
Presentation thumbnail
LCZ696 and drug-drug interactions?
Professor G. Rosano (London, GB)

Access the full session

Session thumbnail
What a busy clinician needs to know about LCZ696 for heart failure

The Event

Event poster

HEART FAILURE 2016

22 May 2016 16:55 CET
You may be interested in
thumbnail
Congress Session
2024 ESC Guidelines overview
30 August 2024
thumbnail
Webinar
ESC Webinar : STEMI: the most important changes in the current guidelines
17 October 2018
thumbnail
Webinar
Translating the 2021 ESC Guidelines on Heart Failure into our daily practice: where do we stand?
22 February 2023
thumbnail
Webinar
Update of the 2019 ESC Guidelines on Management of Dyslipidaemia: new recommendations and their impact on clinical practice
25 November 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources